Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis
Condition(s):MyelofibrosisLast Updated:March 18, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):MyelofibrosisLast Updated:March 18, 2024Recruiting
Condition(s):Melanoma (Skin)Last Updated:September 25, 2012Completed
Condition(s):Self Efficacy; Hepatitis CLast Updated:April 4, 2011Unknown status
Condition(s):Healthy VolunteersLast Updated:November 17, 2014Completed
Condition(s):Healthy ParticipantsLast Updated:February 26, 2024Active, not recruiting
Condition(s):Hepatitis CLast Updated:April 9, 2019Completed
Condition(s):Breast Cancer; Kidney Cancer; Lymphoma; Melanoma; Multiple Myeloma; Sarcoma; Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:October 14, 2015Completed
Condition(s):Breast Cancer; Metastatic CancerLast Updated:December 11, 2012Terminated
Condition(s):Advanced NeoplasmLast Updated:January 30, 2012Completed
Condition(s):Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial; Pulmonary FibrosisLast Updated:April 20, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.